ClinVar Miner

Submissions for variant NM_001105206.3(LAMA4):c.4852C>T (p.Leu1618Phe)

gnomAD frequency: 0.00020  dbSNP: rs397516733
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000037386 SCV000061043 uncertain significance not specified 2014-07-21 criteria provided, single submitter clinical testing The Leu1611Phe variant in LAMA4 has been identified by our laboratory in 1 teena ger with DCM who carried a pathogenic variant in a different gene. It was absent from large population studies. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Leu1611Phe variant is uncertain.
Invitae RCV000545918 SCV000654020 likely benign Dilated cardiomyopathy 1JJ 2023-08-20 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000545918 SCV000743160 likely benign Dilated cardiomyopathy 1JJ 2017-07-28 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000769189 SCV000900565 benign Cardiomyopathy 2018-07-31 criteria provided, single submitter clinical testing
GeneDx RCV001551589 SCV001772124 uncertain significance not provided 2023-05-18 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27532257, 24503780)
Ambry Genetics RCV002336128 SCV002639205 likely benign Cardiovascular phenotype 2019-11-12 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV003944910 SCV004758292 likely benign LAMA4-related condition 2019-11-27 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Clinical Genetics, Academic Medical Center RCV001551589 SCV001925103 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001551589 SCV001955386 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.